Corline Biomedical Stock

Corline Biomedical EBITDA per Employee

The EBITDA per Employee of Corline Biomedical (CLBIO.ST) as of Aug 10, 2026 is -1.78 M SEK. In the previous year, EBITDA per Employee was -2.88 M SEK — a change of -38.41% (higher).

EBITDA per Employee

-1.78 MSEK

YoY

-38.41%

Last updated:

EBITDA per Employee of Corline Biomedical is 2026 -1.78 M SEK. EBITDA per Employee of Corline Biomedical was 2025 -2.88 M SEK. It decreases by -38.41% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

EBITDA per Employee of Corline Biomedical is -1.78 M SEK in 2026.

EBITDA per Employee of Corline Biomedical changed from -2.88 M SEK to -1.78 M SEK, representing a -38.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Corline Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Corline Biomedical

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Corline Biomedical